Navigation Links
WEDI’s HPID Workgroup Announces Release of Issue Brief: “What is the Difference Between a Health Plan and Payer?”
Date:7/28/2014

Reston, VA (PRWEB) July 28, 2014

The Workgroup for Electronic Data Interchange (WEDI), the nation’s leading nonprofit authority on the use of health IT to create efficiencies in healthcare information exchange, announced today its Health Plan Identifier (HPID) Workgroup has developed an issue brief titled, “What is the Difference Between a Health Plan and Payer?” The HPID Workgroup, a part of WEDI’s Strategic National HPID Implementation Process, worked closely with the Centers for Medicare and Medicaid Services (CMS) to identify common misuse of the terms “health plan” and “payer” across the industry.

These terms, often used interchangeably in the regulation, can cause a misconception of an organization’s role. In an effort to help the industry understand the differences in these terms and how to best use them, WEDI partnered with ASC X12 to develop this issue brief, which includes definitions of both terms and clarifies the role each plays in standard transactions according to the HPID Final Rule.

The brief further explains these defined terms as they are affected by the HPID Final Rule compliance date. An organization currently identified as a payer will continue to be identified as such. However, one that is currently identified as a health plan – and continues to be identified as a health plan after November 7, 2016 – must use an HPID.

“The lack of clarity around the definition of a health plan and payer has caused significant challenges among the payer community in the development of their enumeration strategy,” said Devin Jopp, Ed.D, WEDI president and CEO. “It is our hope that these definitions will help provide a common understanding of how to apply these terms across our industry.”

The issue brief is available for review and can be found online here.

About WEDI
The Workgroup for Electronic Data Interchange (WEDI) is the leading authority on the use of health IT to improve healthcare information exchange in order to enhance the quality of care, improve efficiency, and reduce costs of our nation’s healthcare system. WEDI was formed in 1991 by the Secretary of Health and Human Services (HHS) and was designated in the 1996 HIPAA legislation as an advisor to HHS. WEDI’s membership includes a broad coalition of organizations, including: hospitals, providers, health plans, vendors, government agencies, consumers, not-for-profit organizations, and standards development organizations. To learn more, visit http://www.wedi.org and connect with us on Twitter and LinkedIn.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12049054.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort
2. Texas Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry
3. Amgen Announces 2014 Third Quarter Dividend
4. Pittcon 2015 Announces Call for Topics for Conferee Networking Sessions
5. Xybion Announces It Will Host International User Conference in Philadelphia
6. Asterias Biotherapeutics Announces Live Investor Webcast
7. WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division
8. Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology
9. BioAmber announces exercise in full of underwriters option in connection with previously priced follow-on offering
10. SURPASS Announces Two Strategic Hires in Silicon Valley Facility and Launch of Social Media Accounts
11. Pure Energy Group Announces Affiliation with American Biogas Council
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... and PETACH TIKVAH, ... -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a ... for neurodegenerative diseases, announced financial results for ... "2016 was a highly successful and ... achievements and significant progress made on clinical, ...
(Date:3/29/2017)... , March 29, 2017  Halozyme Therapeutics, Inc. ... and drug-delivery therapies, today announced that an Oncologic ... Drug Administration voted 11 to 0 that the ... injection was favorable for patients in the proposed ... and chronic lymphocytic leukemia. The FDA action date ...
(Date:3/29/2017)... CT (PRWEB) , ... March 29, 2017 , ... Bactana ... and hormones in the world’s food supply through enhancement of the gut microbiota, today ... round included Connecticut Innovations , New York-based Sustainable Income Capital Management, LLC and ...
(Date:3/29/2017)... March 29, 2017 /PRNewswire/ -  GeneNews Limited (TSX:GEN) ("GeneNews" ... , a new risk stratification test for breast cancer, via ... Diagnostics Laboratory ("IDL"). BreastSentry incorporates a blood-based biomarker test with ... risk for developing breast cancer.   ... BreastSentry measures the fasting plasma ...
Breaking Biology Technology:
(Date:3/20/2017)... 2017 At this year,s CeBIT Chancellor Dr. ... DERMALOG. The Chancellor came to the DERMALOG stand together with the Japanese ... CeBIT partner country. At the largest German biometrics company the two government ... and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. ... "Eating Well Made Simple," and 23andMe , the ... guide better food choices.  Zipongo can now provide customers ... food preferences, health goals and biometrics, but also genetic ... food choices. Zipongo,s personalized food decision support ...
(Date:3/2/2017)... 2017 Summary This report provides ... KGaA and its partnering interests and activities since 2010. ... Description The Partnering Deals and Alliance since 2010 report ... one of the world,s leading life sciences companies. ... to ensure inclusion of the most up to date ...
Breaking Biology News(10 mins):